General Updates

Supriya Lifescience Limited announced that its Board of Directors recommended a final dividend of Re. 1.00 per equity share (50%) for the financial year 2025-26, subject to shareholder approval at the upcoming Annual General Meeting. The company also informed shareholders about the applicable tax deduction at source (TDS) provisions on this dividend payout, effective from April 1, 2020. This communication details the varying TDS rates based on shareholder category and residential status, along with the required documentation for appropriate tax deduction.